MedPath

GLAXOSMITHKLINE LLC

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.us.gsk.com

Clinical Trials

22

Active:20
Completed:2

Trial Phases

2 Phases

Phase 1:13
Phase 2:2

Drug Approvals

35

FDA:35

Drug Approvals

IMITREX

Approval Date
Mar 22, 2024
FDA

Jemperli

Approval Date
Mar 4, 2024
FDA

IMITREX

Approval Date
Feb 21, 2024
FDA

BENLYSTA

Approval Date
Feb 9, 2024
FDA

Incruse Ellipta

Approval Date
Dec 13, 2023
FDA

MALARONE

Approval Date
Nov 14, 2023
FDA

FLOLAN

Approval Date
Oct 26, 2023
FDA

RELENZA

Approval Date
Oct 24, 2023
FDA

Arnuity Ellipta

Approval Date
Oct 18, 2023
FDA

FLOVENT

Approval Date
Sep 19, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials

Phase 1
13 (86.7%)
Phase 2
2 (13.3%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy